Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
22nd December 2020 | Management Inc. Opaleye | 496,277 | Open or private purchase | $8.06 | $3,999,992.62 |
22nd December 2020 | Management Inc. Opaleye | 657 | Open or private purchase | $5.19 | $3,412.98 |
22nd December 2020 | Management Inc. Opaleye | 15,900 | Open or private purchase | $5.19 | $82,597.32 |
21st December 2020 | Management Inc. Opaleye | 51,400 | Open or private purchase | $5.24 | $269,305.16 |
21st December 2020 | Management Inc. Opaleye | 2,059 | Open or private purchase | $5.24 | $10,787.92 |
18th December 2020 | Management Inc. Opaleye | 35,000 | Open or private purchase | $5.31 | $185,941.00 |
18th December 2020 | Management Inc. Opaleye | 1,400 | Open or private purchase | $5.31 | $7,437.64 |
2nd November 2020 | Charles J Casamento | 3,000 | Open or private sale | $30.29 | $90,863.70 |
21st October 2020 | Management Inc. Opaleye | 3,000 | Open or private purchase | $4.40 | $13,190.70 |
21st October 2020 | Management Inc. Opaleye | 5,656 | Open or private purchase | $4.40 | $24,868.87 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
Eton Pharmaceuticals, Inc. engages in the development and commercialization of prescription drug products. Its portfolio consists of injectable, oral liquid, ophthalmic products pipelines.
12th November 2020
6th November 2020